mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |